The store will not work correctly when cookies are disabled.
1-(3,4-Difluoro-benzyl)-5-methyl-1H-pyrimidine-2,4-dione
ID: ALA365098
Chembl Id: CHEMBL365098
PubChem CID: 5276662
Max Phase: Preclinical
Molecular Formula: C12H10F2N2O2
Molecular Weight: 252.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cn(Cc2ccc(F)c(F)c2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C12H10F2N2O2/c1-7-5-16(12(18)15-11(7)17)6-8-2-3-9(13)10(14)4-8/h2-5H,6H2,1H3,(H,15,17,18)
Standard InChI Key: HQGNIIRBTATAQE-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 252.22 | Molecular Weight (Monoisotopic): 252.0710 | AlogP: 1.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.86 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.21 | CX Basic pKa: ┄ | CX LogP: 1.77 | CX LogD: 1.77 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.87 | Np Likeness Score: -1.79 |
References
1. Douguet D, Munier-Lehmann H, Labesse G, Pochet S.. (2005) LEA3D: a computer-aided ligand design for structure-based drug design., 48 (7): [PMID:15801836] [10.1021/jm0492296] |
2. (2008) Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents, |